- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03588871
Comparison of the Efficacy and Quality of Life of Three Bleaching Products
The aims of this study are: to compare the efficacy of three different dental bleaching products; to evaluate colour relapse following dental bleaching treatment at 1, 3 and 6 months follow up; to evaluate the impact in quality of life from dental bleaching treatments.
Products to be used represent three different techniques and formulations: in office, universal tray and custom tray (respectively VivaStyle Paint On Plus (Ivoclar Vivadent, Liechtenstein), Opalescence GO 6% (Ultradent, USA) and Opalescence PF 15% (Ultradent, USA).
All products contain 6% hydrogen peroxide or its equivalent.
Study Overview
Status
Conditions
Intervention / Treatment
- Other: Dental bleaching with PaintOn Plus VivaStyle
- Other: Dental Bleaching impact in quality of life with PaintOn Plus Vivastyle
- Other: Dental bleaching with Opalescence GO
- Other: Dental Bleaching impact in quality of life with Opalescence GO
- Other: Dental bleaching with Opalescence PF
- Other: Dental Bleaching impact in quality of life with Opalescence PF
Study Type
Enrollment (Anticipated)
Phase
- Phase 4
Contacts and Locations
Study Contact
- Name: João Silveira, Phd, MSc
- Phone Number: +351966168040
- Email: joao.silveira@campus.ul.pt
Study Locations
-
-
-
Lisboa, Portugal
- Recruiting
- Faculty of Dental Medicine of the University of Lisboa
-
Contact:
- João Silveira, Phd, MSc
- Phone Number: +351966168040
- Email: joao.silveira@campus.ul.pt
-
Principal Investigator:
- António Mata, PhD, MSc
-
Sub-Investigator:
- Duarte Marques, PhD, MSc
-
Sub-Investigator:
- João Silveira, PhD, MSc
-
Sub-Investigator:
- Ruben Pereira, MSc
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Be at least 18 years old
- Be willing to refrain from use of tobacco products during the study
- Be willing to sign an informed consent form
- At least one teeth 13,11,21,23,33,43 has a gradable VITA shade A3,5 or darker by clinical assessment
Exclusion Criteria:
- Teeht with restorations in frontal teeth
- Patients with untreated periodontitis or caries
- Patients with fixed orthodontics appliances
- Patients with know allergies to ingredients
- Patients who are nursing or pregnant
- Patients with severe systemic illnesses
- Patients with development tooth anomalies
- Patients with non vital anterior teeth
- Patients with insufficient oral hygiene
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Group A
Dental bleaching with PaintOn Plus, HP 6%, 6x10min, two sessions
|
Procedure of tooth bleaching using products with 6% hydrogen peroxide or its equivalent, specifically the PaintOn Plus Vivastyle 6% HP (Ivoclar Vivadent)
Evaluation of oral quality of life after dental bleaching treatment with PaintOn Plus Vivastyle 6% HP (Ivoclar Vivadent) using an oral quality of life measuring questionnaire, specifically the Oral Health Impact Profile-14
|
Experimental: Group B
Dental bleaching with Opalescence GO, HP 6%, 10x60min
|
Procedure of tooth bleaching using products with 6% hydrogen peroxide or its equivalent, specifically the Opalescence GO 6% HP (Ultradent)
Evaluation of oral quality of life after dental bleaching treatment with Opalescence GO 6% HP (Ultradent) using an oral quality of life measuring questionnaire, specifically the Oral Health Impact Profile-14
|
Experimental: Group C
Dental bleaching with Opalescence PF, CP 16%, 14x60h
|
Procedure of tooth bleaching using products with 6% hydrogen peroxide or its equivalent, specifically the Opalescence PF 16% CP (Ultradent)
Evaluation of oral quality of life after dental bleaching treatment with Opalescence PF 16% CP (Ultradent) using an oral quality of life measuring questionnaire, specifically the Oral Health Impact Profile-14
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change on visually determination of tooth colour
Time Frame: 2 weeks (before and after treatment)
|
Determination of tooth colour using a visual tooth shade guide
|
2 weeks (before and after treatment)
|
Change on spectrophotometer determination of tooth colour
Time Frame: 2 weeks (before and after treatment)
|
Determination of tooth colour using a spectrophotometer
|
2 weeks (before and after treatment)
|
Subjective evaluation of tooth colour change during follow-up
Time Frame: 1, 3 and 6 months
|
Determination of tooth colour relapse using visual tooth shade guide (VITA shade guide)
|
1, 3 and 6 months
|
Change on quality of life during treatment and follow-up
Time Frame: 2 weeks (before and after treatment), 1 month, 3 months and 6 months
|
Impact on quality of life using an oral quality of life measuring questionnaire, the Oral Health Impact Profile 14 (OHIP-14).
The OHIP-14 ranges from 0 to 56 (final sum of all the seven subscales), with higher scores indicating poorer quality of life.
|
2 weeks (before and after treatment), 1 month, 3 months and 6 months
|
Objective evaluation of tooth colour change during follow-up
Time Frame: 1, 3 and 6 months
|
Determination of tooth colour relapse using a spectrophotometer
|
1, 3 and 6 months
|
Collaborators and Investigators
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- BL16001
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Quality of Life
-
Assiut UniversityUnknownImproving Quality of LifeEgypt
-
B. Braun Medical SAUnknownQuality of Life of Colostomized Patient
-
Children's National Research InstituteRecruitingProfessional Quality of LifeUnited States
-
Istituto Ortopedico RizzoliUniversity of BolognaRecruitingImprove Quality of LifeItaly
-
Mattu UniversityCompletedBreif Description: Patients' Quality of Life ofEthiopia
-
University of South CarolinaNational Institute on Minority Health and Health Disparities (NIMHD)RecruitingHealth Related Quality of LifeUnited States
-
PharmanexSprim Advanced Life SciencesCompletedHealth-related Quality of LifeUnited States
-
Linkoeping UniversityRecruiting
-
South Valley UniversityActive, not recruitingDeterminants of Health-related Quality of Life for Patients After Renal Lithotripsy: PNL Versus RIRSHealth Related Quality of LifeEgypt
-
Region VästmanlandUnknownHealth Related Quality of Life
Clinical Trials on Dental bleaching with PaintOn Plus VivaStyle
-
Universidade IbirapueraFundação de Amparo à Pesquisa do Estado de São PauloUnknown
-
Universidade Federal de Santa MariaCompleted